Alejandro D Ricart Selected Research

Alejandro D Ricart Research Topics

Disease

16	Neoplasms (Cancer) 12/2019 - 12/2005
7	Fatigue 03/2016 - 06/2008
4	Nausea 03/2016 - 12/2008
3	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 11/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2012 - 06/2008
3	Neutropenia 10/2011 - 12/2005
3	Thrombocytopenia (Thrombopenia) 10/2011 - 12/2005
3	Anorexia 10/2011 - 12/2008
2	Lymphoma (Lymphomas) 07/2017 - 10/2011
2	Hypertension (High Blood Pressure) 03/2016 - 03/2011
2	Fever (Fevers) 12/2014 - 12/2008
2	Diarrhea 12/2013 - 10/2011
2	Vomiting 10/2011 - 12/2008
2	Headache (Headaches) 10/2011 - 12/2008
2	Melanoma (Melanoma, Malignant) 08/2011 - 12/2008
2	Abdominal Pain (Pain, Abdominal) 03/2011 - 06/2008
1	Disease Progression 11/2016
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Proteinuria 03/2016
1	Colorectal Neoplasms (Colorectal Cancer) 12/2013
1	Dizziness (Lightheadedness) 02/2013
1	Hyperbilirubinemia 10/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2011
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Toxic Optic Neuropathy 08/2011
1	Colonic Neoplasms (Colon Cancer) 08/2011
1	Adenocarcinoma 03/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2010
1	Breast Diseases (Breast Disease) 06/2009
1	Prostatic Neoplasms (Prostate Cancer) 06/2009
1	Asthenia 06/2008

Drug/Important Bio-Agent (IBA)

5	Axitinib (AG 013736)IBA 12/2013 - 06/2008
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013 - 06/2008
3	Brentuximab VedotinIBA 01/2019 - 11/2016
3	Pharmaceutical PreparationsIBA 03/2016 - 04/2007
3	Gemcitabine FDA Link 08/2012 - 06/2008
3	mirdametinibIBA 08/2011 - 03/2010
2	pembrolizumabIBA 07/2017 - 11/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 03/2011
2	Immunoconjugates (Immunoconjugate)IBA 10/2011 - 04/2007
2	Mitogen-Activated Protein KinasesIBA 04/2010 - 03/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2010 - 03/2010
2	Phosphotransferases (Kinase)IBA 04/2010 - 03/2010
2	Cisplatin (Platino)FDA LinkGeneric 12/2008 - 12/2005
1	ribociclibIBA 12/2019
1	Cyclin-Dependent Kinase 4IBA 12/2019
1	Cyclin DIBA 12/2019
1	LigandsIBA 11/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2016
1	Hemoglobins (Hemoglobin)IBA 03/2016
1	Troponin IIBA 03/2016
1	PF 00337210IBA 03/2016
1	PF-05280014IBA 12/2014
1	Leucovorin (Folinic Acid)FDA Link 12/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2013
1	Fluorouracil (Carac)FDA LinkGeneric 12/2013
1	Bevacizumab (Avastin)FDA Link 12/2013
1	Docetaxel (Taxotere)FDA Link 02/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2013
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2013
1	Cytotoxins (Cytolysins)IBA 10/2011
1	Transaminases (Aminotransferases)IBA 10/2011
1	Inotuzumab OzogamicinIBA 10/2011
1	denibulinIBA 10/2011
1	Biomarkers (Surrogate Marker)IBA 06/2011
1	N- (3- cyano- 4- methyl- 1H- indol- 7- yl)- 3- cyanobenzene- sulfonamideIBA 01/2011
1	IntegrinsIBA 01/2011
1	EnzymesIBA 01/2011
1	SulfonamidesIBA 01/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2010
1	satraplatin (JM 216)IBA 06/2009
1	Hormones (Hormone)IBA 06/2009
1	Biological ProductsIBA 12/2008
1	Integrin alpha5beta1IBA 12/2008
1	volociximabIBA 12/2008
1	Thymidylate SynthaseIBA 12/2008
1	((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA 12/2008
1	Sirolimus (Rapamycin)FDA Link 01/2008
1	ridaforolimusIBA 01/2008
1	TOR Serine-Threonine KinasesIBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 04/2007
1	Gemtuzumab (Mylotarg)FDA Link 04/2007
1	AntigensIBA 04/2007
1	Immunoglobulins (Immunoglobulin)IBA 04/2007
1	Monoclonal AntibodiesIBA 04/2007
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2005
1	rebeccamycinIBA 12/2005
1	becatecarin (XL 119)IBA 12/2005

Therapy/Procedure

4	Therapeutics 12/2019 - 04/2007
3	Drug Therapy (Chemotherapy) 07/2017 - 08/2012
1	Stem Cell Transplantation 07/2017
1	Transplantation 07/2017
1	Precision Medicine 10/2011
1	Immunotherapy 04/2007